Erratum (DOI:10.1016/j.tcm.2009.04.007);Prokineticin Receptors in Cardiovascular Function: Foe or Friend?

Trends in Cardiovascular Medicine

Volumn 19, Issue 2, 2009, Pages 55-60

  Nebigil, Canan G ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIAZIN 4,6 DIONE DERIVATIVE; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANGIOGENESIS; BIOLOGICAL ACTIVITY; CAPILLARY LEAK SYNDROME; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CELL FUNCTION; CONGESTIVE CARDIOMYOPATHY; DRUG TARGETING; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE THERAPY; GENETIC DISORDER; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION; VASCULARIZATION;

EID: 67649424757     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.09.001     Document Type: Erratum

References (48)

1. Adams J.W., and Brown J.H. G-proteins in growth and apoptosis: Lessons from the heart. Oncogene 20 (2001) 1626-1634
2. Attramadal H. Prokineticins and the heart: Diverging actions elicited by signalling through prokineticin receptor-1 or -2. Cardiovasc Res 81 (2009) 3-4
3. Balboni G., Lazzari I., Trapella C., et al. Triazine compounds as antagonists at Bv8-prokineticin receptors. J Med Chem (2008) 7635-7639
4. Chen J., Kuei C., Sutton S., et al. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. Mol Pharmacol 67 (2005) 2070-2076
5. Choke E., Cockerill G.W., Laing K., et al. Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 37 (2009) 305-310
6. Cole L.W., Sidis Y., Zhang C., et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab 93 (2008) 3551-3559
7. Goi T., Fujioka M., Satoh Y., et al. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 64 (2004) 1906-1910
8. Guilini C., Turkeri G., Urayama K., et al. Angiogenesis and fenestration: Divergent role of prokineticin receptors in endothelial cell functions. Hypertension (2009) (accepted)
9. Hardelin J.P., and Dodé C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2 (2008) 181-193
10. Howes A.L., Miyamoto S., Adams J.W., et al. Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: Dissociation from Galphaq mediated hypertrophy. J Mol Cell Cardiol 40 (2006) 597-604
11. Hu W.P., Zhang C., Li J.D., et al. Impaired pain sensation in mice lacking prokineticin 2. Mol Pain 2 (2006) 35
12. Hu W.P., Li J.D., Zhang C., et al. Altered circadian and homeostatic sleep regulation in prokineticin 2-deficient mice. Sleep 30 (2007) 247-256
13. Kaser A., Winklmayr M., Lepperdinger G., and Kreil G. The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep 4 (2003) 469-473
14. Kisliouk T., Podlovni H., Spanel-Borowski K., et al. Prokineticins (endocrine gland-derived vascular endothelial growth factor and BV8) in the bovine ovary: Expression and role as mitogens and survival factors for corpus luteum-derived endothelial cells. Endocrinology 146 (2005) 3950-3958
15. Koyama Y., Kiyo-oka M., Osakada M., et al. Expression of prokineticin receptors in mouse cultured astrocytes and involvement in cell proliferation. Brain Res 1112 (2006) 65-69
16. Kruithof B.P., van Wijk B., Somi S., et al. BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol 295 (2006) 507-522
17. Kurose H. Galpha12 and Galpha13 as key regulatory mediator in signal transduction. Life Sci 74 (2003) 155-161
18. LeCouter J., Kowalski J., Foster J., et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412 (2001) 877-884
19. LeCouter J., Lin R., Tejada M., et al. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci U S A 100 (2003) 2685-2690
20. LeCouter J., Zlot C., Tejada M., et al. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci U S A 101 (2004) 16813-16818
21. Li J.D., Hu W.P., Boehmer L., et al. Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 26 (2006) 11615-11623
22. Li J.D., Hu W.P., and Zhou Q.Y. Disruption of the circadian output molecule prokineticin 2 results in anxiolytic and antidepressant-like effects in mice. Neuropsychopharmacology 34 (2009) 367-373
23. Li M., Bullock C.M., Knauer D.J., et al. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 59 (2001) 692-698
24. Martucci C., Franchi S., Giannini E., et al. Bv8, the amphibian homolouge of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol 147 (2006) 225-234
25. Masuda Y., Takatsu Y., Terao Y., et al. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 293 (2002) 396-402
26. Matsumoto S., Yamasaki C., Masumoto K.H., et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci U S A 103 (2006) 4140-4145
27. Nagoshi T., Matsui T., Aoyama T., et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115 (2005) 2128-2138
28. Nebigil C.G., Etienne N., Le Cunff M., et al. Serotonin is a novel survival factor of cardiomyocytes: Mitochondria as a target of 5-HT2B receptor signaling. FASEB J 17 (2003) 1373-1375
29. Negri L., Lattanzi R., Giannini E., et al. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and capsaicin receptor TRPV1 in pain behavior. J Neurosci 26 (2006) 6716-6727
30. Ng K.L., Li J.D., Cheng M.Y., et al. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 308 (2005) 1923-1927
31. Ngan E.S., Lee K.Y., Sit F.Y., et al. Prokineticin-1 modulates proliferation and differentiation of enteric neural crest cells. Biochim Biophys Acta 1773 (2007) 536-545
32. Ngan E.S., and Tam P.K. Prokineticin-signaling pathway. Int J Biochem Cell Biol 40 (2008) 1679-1684
33. Nicol R.L., Frey N., Pearson G., et al. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 20 (2001) 2757-2767
34. Pasquali R., and Gambineri A. Polycyctic ovary syndrome: a multifaceted disease from adoloscence to adult age. Ann NY Acad Sci 1092 (2006) 158-174
35. Pitteloud N., Zhang C., Pignatelli D., et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A 104 (2007) 17447-17452
36. Podlovni H., Ovadia O., Kisliouk T., et al. Differential expression of prokineticin receptors by endothelial cells derived from different vascular beds: A physiological basis for distinct endothelial function. Cell Physiol Biochem 18 (2006) 315-326
37. Prosser H.M., Bradley A., and Caldwell M.A. Olfactory bulb hypoplasia in Prokr2 null mice stems from defective neuronal progenitor migration and differentiation. Eur J Neurosci 26 (2007) 3339-3344
38. Sabath E., Negoro H., Beaudry S., et al. Galpha12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J Cell Sci 121 (2008) 814-824
39. Samson M., Peale F.V., Frantz G., et al. Human endocrine gland-derived vascular endothelial growth factor: expression early in development and Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 89 (2004) 4078-4088
40. Sawada K., and Kawamura K. Architecture of myocardial cells in human cardiac ventricles with concentric and eccentric hypertrophy as demonstrated by quantitative scanning electron microscopy. Heart Vessels 6 (1991) 129-142
41. Shojaei F., Wu X., Zhong C., et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450 (2007) 825-831
42. Smart N., Risebro C.A., Melville A.A., et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445 (2007) 177-182
43. Tanaka N., Ikawa M., Mata N.L., et al. Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration. Mol Ther 13 (2005) 609-616
44. Urayama K., Dedeoglu D.B., Guilini C., et al. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage. Cardiovasc Res 81 (2009) 28-37
45. Urayama K., Guilini C., Messaddeq N., et al. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. FASEB J 21 (2007) 2980-2993
46. Urayama K., Guilini C., Turkeri G., et al. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation. Arterioscler Thromb Vasc Biol 28 (2008) 841-849
47. Weis S.M., and Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437 (2005) 497-504
48. Wessels A., and Perez-Pomares J.M. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec A Discov Mol Cell Evol Biol 276 (2004) 43-57